Home › Funds › Citadel Advisors › PLRX
Citadel Advisors position in PLRX
PLIANT THERAPEUTICS INC · Health Care
Latest position (Q2 2026)2.14M sh
Reported value held$2.44M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.34M | $22.67M | New |
| Q4 2021 | 1.34M | $18.05M | Hold |
| Q1 2022 | 1.38M | $9.66M | Add |
| Q2 2022 | 1.40M | $11.24M | Add |
| Q3 2022 | 515.29K | $10.77M | Reduce |
| Q4 2022 | 1.06M | $20.53M | Add |
| Q1 2023 | 1.21M | $32.31M | Add |
| Q2 2023 | 1.69M | $30.64M | Add |
| Q3 2023 | 1.60M | $27.70M | Reduce |
| Q4 2023 | 1.64M | $29.64M | Add |
| Q1 2024 | 1.79M | $26.63M | Add |
| Q2 2024 | 523.71K | $5.63M | Reduce |
| Q3 2024 | 112.95K | $1.27M | Reduce |
| Q4 2024 | 494.49K | $6.51M | Add |
| Q1 2025 | 45.16K | $60.97K | Reduce |
| Q2 2025 | 2.43M | $2.82M | Add |
| Q3 2025 | 2.37M | $3.51M | Reduce |
| Q4 2025 | 2.71M | $3.30M | Add |
| Q1 2026 | 3.26M | $4.11M | Add |
| Q2 2026 | 2.14M | $2.44M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PLRX
- Vanguard Group 2.82M sh · $3.44M · Q4 2025
- Two Sigma Investments 2.26M sh · $2.58M · Q2 2026
- Renaissance Technologies 2.05M sh · $2.34M · Q2 2026
- BlackRock Inc 1.15M sh · $1.31M · Q2 2026
- Marshall Wace 835.12K sh · $952.04K · Q2 2026
- JPMorgan Chase & Co 681.65K sh · $783.89K · Q2 2026
- Geode Capital Management 578.58K sh · $659.95K · Q2 2026
- UBS Group AG 571.76K sh · $651.81K · Q2 2026
- Millennium Management 559.45K sh · $637.77K · Q2 2026
- Morgan Stanley 298.98K sh · $340.83K · Q2 2026
- Goldman Sachs Group 208.59K sh · $237.79K · Q2 2026